EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Findings and significance of early follow-up biopsies after treatment of acute rejection in kidney transplant recipients

Amanda Ahlmark, Kaisa Ahopelto, Anne Räisänen-Sokolowski, Jouni Lauronen, Marko Lempinen, Ville Sallinen, Ilkka Helanterä

Transplant International · 13.08.2026 · 39

DOI: 10.3389/ti.2026.16296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, online erschienen am 13.08.2026. Verfasst von Amanda Ahlmark und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsingin Yliopisto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment resistant acute rejection after kidney transplantation is linked to inferior outcomes, yet many centers do not routinely perform follow-up biopsies. The optimal timing of such biopsies remains uncertain. We evaluated findings from follow-up biopsies performed ≤45 days after treatment of acute rejection and assessed their association with long-term outcomes. Adult kidney transplants performed from 01/2014 to 07/2024 were included (n = 2,420). Acute rejections were classified according to Banff criteria. T-cell–mediated rejection, including borderline TCMR changes, was treated with pulse steroids; antibody-mediated rejection was treated with steroids, intravenous immunoglobulin, and plasma exchange. Findings from follow-up biopsies taken ≤45 days after treatment of early acute rejection were correlated with graft outcomes. Of 383 patients (16%) with acute rejection within 3 months post-transplant, 221 underwent a follow-up biopsy ≤45 days. Of these, 50% were taken by protocol and 50% because of clinical reasons. In 164 cases (74%), rejection changes had resolved. At 1-year, median creatinine was 1.3 mg/dL in those without rejection, 1.6 mg/dL in patients with persistent changes, and 1.5 mg/dL in those with resolved changes. Persistent histologic rejection within 45 days was associated with inferior long-term graft survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionHumansFemaleBiopsyMaleMiddle AgedAdultFollow-Up StudiesAcute DiseaseGraft SurvivalKidneyRetrospective StudiesTreatment OutcomeImmunosuppressive Agents

Stichwörter der Autor:innen

acute rejectionfollow-up biopsieshistologykidney transplantationoutcomes

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Department of Pathology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Finnish Red Cross Blood Service, Vantaa, Finland.

Förderung

  • Helsingin Yliopisto

Zitieren

APA

Ahlmark, A., Ahopelto, K., Räisänen-Sokolowski, A., Lauronen, J., Lempinen, M., Sallinen, V., & Helanterä, I. (2026). Findings and significance of early follow-up biopsies after treatment of acute rejection in kidney transplant recipients. Transplant International, 39. https://doi.org/10.3389/ti.2026.16296

Vancouver

Ahlmark A, Ahopelto K, Räisänen-Sokolowski A, Lauronen J, Lempinen M, Sallinen V, et al. Findings and significance of early follow-up biopsies after treatment of acute rejection in kidney transplant recipients. Transplant International. 2026;39. doi:10.3389/ti.2026.16296

BibTeX
@article{Ahlmark2026,
  author = {Ahlmark, Amanda and Ahopelto, Kaisa and Räisänen-Sokolowski, Anne and Lauronen, Jouni and Lempinen, Marko and Sallinen, Ville and Helanterä, Ilkka},
  title = {Findings and significance of early follow-up biopsies after treatment of acute rejection in kidney transplant recipients},
  journal = {Transplant International},
  year = {2026},
  volume = {39},
  doi = {10.3389/ti.2026.16296}
}
Kostenlos starten →